Klaus Tiroch

5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

Gjin Ndrepepa, Klaus Tiroch, Massimiliano Fusaro et al. · Journal of the American College of Cardiology · 2010 · 459 citations

Thrombosis, Percutaneous Coronary Intervention, Cardiogenic Shock +9

Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial

Robert A. Byrne, Franz–Josef Neumann, Julinda Mehilli et al. · The Lancet · 2012 · 441 citations

Endovascular Technique, Cardiovascular Disease, Paclitaxel-eluting Balloons +7

Percutaneous Mitral Valve Edge-to-Edge Repair

Georg Nickenig, Rodrigo Estévez‐Loureiro, Olaf Franzen et al. · Journal of the American College of Cardiology · 2014 · 425 citations · Full text

Valve Disease, Surgery, Valvular Heart Disease

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting

Stefanie Schüpke, Robert A. Byrne, Jurriën M. ten Berg et al. · European Heart Journal · 2015 · 423 citations · Full text

Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents

Julinda Mehilli, Robert A. Byrne, Klaus Tiroch et al. · Journal of the American College of Cardiology · 2010 · 208 citations

Percutaneous Coronary Intervention, Coronary Restenosis, Cardiovascular Disease +8